| Serial Number | 90033606 |
| Word Mark | MACH-1 |
| Filing Date | Thursday, July 2, 2020 |
| Status | 606 - ABANDONED - NO STATEMENT OF USE FILED |
| Status Date | Monday, August 19, 2024 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, May 18, 2021 |
| Goods and Services | vaccines; vaccine preparations; medical preparations for the treatment of autoimmune diseases, infectious diseases, respiratory diseases, mucosal diseases, multiple sclerosis, type 1 diabetes; pharmaceutical preparations and substances for the treatment of autoimmune diseases, infectious diseases, respiratory diseases, mucosal diseases, multiple sclerosis, type 1 diabetes; chemical preparations for the treatment of diseases affecting mucosal tissues, the immune system, respiratory tissues; chemical preparations for pharmaceutical purposes, namely, for autoimmune diseases, infectious diseases, respiratory diseases, mucosal diseases, multiple sclerosis, type 1 diabetes; chemical preparations for medical purposes, namely, for autoimmune diseases, infectious diseases, respiratory diseases, mucosal diseases, multiple sclerosis, type 1 diabetes |
| Pseudo Mark | MACH-ONE |
| Goods and Services | medical services; medical testing for treatment purposes; medical analysis services for diagnostic and treatment purposes provided by medical laboratories; medical evaluation services of autoimmune diseases, infectious diseases, respiratory diseases, mucosal diseases, multiple sclerosis, type 1 diabetes; medical treatment of autoimmune diseases, infectious diseases, respiratory diseases, mucosal diseases, multiple sclerosis, type 1 diabetes |
| Goods and Services | research and development of vaccines; research and development of medicines; medical research; scientific research; clinical research; all in the field of autoimmune diseases, infectious diseases, respiratory diseases, mucosal diseases, multiple sclerosis, type 1 diabetes, immunotherapy |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, July 30, 2020 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, July 30, 2020 |
| Primary Code | 044 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, July 30, 2020 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Orlance, Inc. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | Seattle, WA 98104 |
| Party Name | Orlance, Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Seattle, WA 98104 |
| Event Date | Event Description |
| Monday, July 6, 2020 | NEW APPLICATION ENTERED |
| Thursday, July 30, 2020 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Thursday, October 8, 2020 | ASSIGNED TO EXAMINER |
| Thursday, October 8, 2020 | NON-FINAL ACTION WRITTEN |
| Thursday, October 8, 2020 | NON-FINAL ACTION E-MAILED |
| Thursday, October 8, 2020 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Thursday, April 8, 2021 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Thursday, April 8, 2021 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Friday, April 9, 2021 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Monday, April 12, 2021 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, April 28, 2021 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, May 18, 2021 | PUBLISHED FOR OPPOSITION |
| Tuesday, May 18, 2021 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, July 13, 2021 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Tuesday, January 11, 2022 | SOU TEAS EXTENSION RECEIVED |
| Tuesday, January 11, 2022 | SOU EXTENSION 1 FILED |
| Tuesday, January 11, 2022 | SOU EXTENSION 1 GRANTED |
| Thursday, January 13, 2022 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Friday, July 1, 2022 | SOU TEAS EXTENSION RECEIVED |
| Friday, July 1, 2022 | SOU EXTENSION 2 FILED |
| Friday, July 1, 2022 | SOU EXTENSION 2 GRANTED |
| Tuesday, July 5, 2022 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Wednesday, January 11, 2023 | SOU TEAS EXTENSION RECEIVED |
| Wednesday, January 11, 2023 | SOU EXTENSION 3 FILED |
| Wednesday, January 11, 2023 | SOU EXTENSION 3 GRANTED |
| Friday, January 13, 2023 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Friday, June 16, 2023 | SOU TEAS EXTENSION RECEIVED |
| Friday, June 16, 2023 | SOU EXTENSION 4 FILED |
| Friday, June 16, 2023 | SOU EXTENSION 4 GRANTED |
| Tuesday, June 20, 2023 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Friday, December 29, 2023 | SOU TEAS EXTENSION RECEIVED |
| Friday, December 29, 2023 | SOU EXTENSION 5 FILED |
| Thursday, January 18, 2024 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| Thursday, January 18, 2024 | SOU EXTENSION 5 GRANTED |
| Friday, January 19, 2024 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Monday, August 19, 2024 | ABANDONMENT - NO USE STATEMENT FILED |
| Monday, August 19, 2024 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED |